Raymond James & Associates’s Varex Imaging VREX Stock Holding History
Bought
Maintained
Sold
Other funds holding VREX
SCM
CB
Raymond James & Associates's VREX Position: Q2 2022 in Review
Raymond James & Associates sold out of Varex Imaging (VREX) in Q2 2022, closing a stake of 11,042 shares — an estimated $235K sold.
Raymond James & Associates first reported a position in VREX in Q1 2017 and held it in 12 quarters. The position peaked at $2.01M in Q3 2018. 177 funds tracked by Wall St. Rank hold VREX as of Q2 2022.
- Raymond James & Associates reported no remaining Varex Imaging position as of Q2 2022 after selling out during the quarter.
- Raymond James & Associates sold 11,042 Varex Imaging shares in Q2 2022, an estimated $235K.
- Raymond James & Associates first reported a position in Varex Imaging in Q1 2017 and held it in 12 quarters.
- Raymond James & Associates's Varex Imaging position peaked at $2.01M in Q3 2018.
- 177 funds tracked by Wall St. Rank held Varex Imaging as of Q2 2022.
Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.